Longaeva Partners »

Pmv Pharmaceuticals shares owned by Longaeva Partners

Quarter-by-quarter ownership of Pmv Pharmaceuticals (PMVP) shares owned by Longaeva Partners from 13F filings

Historical chart of Longaeva Partners investment in Pmv Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Pmv Pharmaceuticals held by Longaeva Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Pmv Pharmaceuticals by Longaeva Partners

Quarter filed Position value Share count Share price at filing
2026-03-31 $685k 552k 1.24

More positions owned by Longaeva Partners

Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Boston Scientific Corporation Call Option (BSX)
Bank of America Corporation (BAC)
NVIDIA Corporation Call Option (NVDA)
PNC Financial Services (PNC)
Key (KEY)
Goldman Sachs (GS)
Morgan Stanley Com New (MS)
Minimed Group
Citizens Financial (CFG)
Evercore Class A (EVR)
Mastercard Incorporated Cl A (MA)
Msci (MSCI)
S&p Global (SPGI)
Us Bancorp Com New (USB)

View all positions for Longaeva Partners

Top funds holding Pmv Pharmaceuticals

BML Capital Management
Tang Capital Management
Arrowpoint Asset Management
Sio Capital Management
Euclidean Capital
Acadian Asset Management
Vanguard Group
Vanguard Capital Management
Two Sigma Investments
Stonepine Capital Management
BlackRock
Morgan Stanley
Longaeva Partners
Geode Capital Management
Aldebaran Capital

View all funds holding Pmv Pharmaceuticals